Peter Verdult

Stock Analyst at Citigroup

(n/a)
# 4,704
Out of 4,962 analysts
5
Total ratings
n/a
Success rate
-30.13%
Average return

Stocks Rated by Peter Verdult

Eli Lilly and Company
Jan 28, 2025
Maintains: Buy
Price Target: $1,250$1,190
Current: $711.68
Upside: +67.21%
Evotec SE
Jun 8, 2023
Upgrades: Buy
Price Target: n/a
Current: $3.64
Upside: -
Galapagos NV
Jan 27, 2022
Upgrades: Buy
Price Target: n/a
Current: $32.00
Upside: -